Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Statistics

Total Valuation

TPEX:6620 has a market cap or net worth of TWD 16.68 billion. The enterprise value is 14.11 billion.

Market Cap	16.68B
Enterprise Value	14.11B

Important Dates

The next estimated earnings date is Friday, December 26, 2025.

Earnings Date	Dec 26, 2025
Ex-Dividend Date	Jul 2, 2025

Share Statistics

TPEX:6620 has 157.33 million shares outstanding. The number of shares has increased by 6.72% in one year.

Current Share Class	157.33M
Shares Outstanding	157.33M
Shares Change (YoY)	+6.72%
Shares Change (QoQ)	+3.28%
Owned by Insiders (%)	3.61%
Owned by Institutions (%)	2.32%
Float	101.36M

Valuation Ratios

The trailing PE ratio is 23.39.

PE Ratio	23.39
Forward PE	n/a
PS Ratio	10.31
PB Ratio	3.71
P/TBV Ratio	4.49
P/FCF Ratio	94.95
P/OCF Ratio	85.85
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.21, with an EV/FCF ratio of 80.34.

EV / Earnings	20.66
EV / Sales	8.72
EV / EBITDA	14.21
EV / EBIT	16.27
EV / FCF	80.34

Financial Position

The company has a current ratio of 32.44, with a Debt / Equity ratio of 0.01.

Current Ratio	32.44
Quick Ratio	32.25
Debt / Equity	0.01
Debt / EBITDA	0.05
Debt / FCF	0.28
Interest Coverage	927.94

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	18.81%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TPEX:6620 has paid 173.53 million in taxes.

Income Tax	173.53M
Effective Tax Rate	20.26%

Stock Price Statistics

The stock price has increased by +98.50% in the last 52 weeks. The beta is 0.89, so TPEX:6620's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+98.50%
50-Day Moving Average	126.26
200-Day Moving Average	94.26
Relative Strength Index (RSI)	33.66
Average Volume (20 Days)	479,431

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6620 had revenue of TWD 1.62 billion and earned 683.16 million in profits. Earnings per share was 4.53.

Revenue	1.62B
Gross Profit	1.39B
Operating Income	866.70M
Pretax Income	856.69M
Net Income	683.16M
EBITDA	981.06M
EBIT	866.70M
Earnings Per Share (EPS)	4.53

Balance Sheet

The company has 2.61 billion in cash and 49.17 million in debt, giving a net cash position of 2.57 billion or 16.31 per share.

Cash & Cash Equivalents	2.61B
Total Debt	49.17M
Net Cash	2.57B
Net Cash Per Share	16.31
Equity (Book Value)	4.49B
Book Value Per Share	28.54
Working Capital	3.04B

Cash Flow

In the last 12 months, operating cash flow was 194.26 million and capital expenditures -18.62 million, giving a free cash flow of 175.65 million.

Operating Cash Flow	194.26M
Capital Expenditures	-18.62M
Free Cash Flow	175.65M
FCF Per Share	1.12

Margins

Gross margin is 85.78%, with operating and profit margins of 53.58% and 42.24%.

Gross Margin	85.78%
Operating Margin	53.58%
Pretax Margin	52.97%
Profit Margin	42.24%
EBITDA Margin	60.66%
EBIT Margin	53.58%
FCF Margin	10.86%

Dividends & Yields

This stock pays an annual dividend of 1.51, which amounts to a dividend yield of 1.38%.

Dividend Per Share	1.51
Dividend Yield	1.38%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	34.59%
Buyback Yield	-6.72%
Shareholder Yield	-5.34%
Earnings Yield	4.10%
FCF Yield	1.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6620 has an Altman Z-Score of 34.6 and a Piotroski F-Score of 2.

Altman Z-Score	34.6
Piotroski F-Score	2